AzTrials
AzTrials

AnesthesiaNCT05569460

Construction of Perioperative Medical Data Platform and Its Typical Practice to Predict Postoperative Acute Moderate to Severe Pain With Machine Learning Models

An observational study of Anesthesia and Acute Pain, run by Guangdong Second Provincial General Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Data intelligence platform was widely used to facilitate the process of clinical research. However, a platform that integrates natural language processing (NLP) and machine learning (ML) algorithms has not been reported in perioperative medical management. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Anesthesia, Acute Pain, Risk Reduction
How many people
6,500 participants
Where
1 siteChina
Study dates
Oct 2022to Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Pain assessment was used by Numeric Rating Scale (NRS) score after surgery.

Who may be able to join

  • Patients were included if they were above 18 years old, undergoing non-local anesthesia surgery.

Who cannot join

  • The basic information such gender, age, height, weight, and body mass index (BMI) were missing.
  • Patients undergoing day surgery, with a history of multiple operations, or entering ICU after surgery, and losing the NRS score during movement at 24h after surgery.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Guangdong Second Provincial General Hospital

    Guangzhou

    Hui Zhang, 13719136792, zhanghui@gd2h.org.cn

    Recruiting

Other trials in China

About this study

Data intelligence platform was widely used to facilitate the process of clinical research. However, a platform that integrates natural language processing (NLP) and machine learning (ML) algorithms has not been reported in perioperative medical management.

Being tested
No intervention
Keywords
Data Platform, Machine Learning, Postoperative Acute Pain
Medical subject headings
Acute Pain, Risk Reduction Behavior, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    No intervention

Study groups in NCT05569460
Study groupRoleWhat they receive
Numeric Rating Scale (NRS) score after surgery <4Not described
Receives: Other: No intervention
Numeric Rating Scale (NRS) score after surgery ≥ 4Not described
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Area under the curve

    It measures the prediction effect of the algorithm model

    Measured: April 2020 to May 2021

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2022
  2. Study startOct 2022 (estimated)
  3. Primary completionOct 2023 (estimated)
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
6,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05569460
Sponsor's protocol ID
Guangdong2nd
Status last verified
Oct 2022
First submitted
3 Oct 2022
Last updated
6 Oct 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia and Acute Pain, run by Guangdong Second Provincial General Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Area under the curve (time frame: April 2020 to May 2021). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in